Comparative Pharmacology
Head-to-head clinical analysis: PRASUGREL versus PRAVIGARD PAC COPACKAGED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRASUGREL versus PRAVIGARD PAC COPACKAGED.
PRASUGREL vs PRAVIGARD PAC (COPACKAGED)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prasugrel is a thienopyridine prodrug that irreversibly inhibits the P2Y12 receptor on platelets, blocking ADP binding and preventing platelet aggregation.
Pravigard PAC (copackaged) contains pravastatin, an HMG-CoA reductase inhibitor that competitively inhibits the conversion of HMG-CoA to mevalonate, reducing cholesterol synthesis, and buffered aspirin, which irreversibly acetylates cyclooxygenase (COX-1 and COX-2), inhibiting thromboxane A2 synthesis and platelet aggregation.
60 mg orally once daily as a loading dose, then 10 mg orally once daily maintenance
PRAVIGARD PAC (copackaged) is not a single drug but a copackaged product containing pravastatin and aspirin. The typical adult dose of pravastatin is 40 mg orally once daily; aspirin is 81 mg orally once daily. Both are taken together as a single daily dose.
None Documented
None Documented
Clinical Note
moderatePrasugrel + Tranilast
"Prasugrel may increase the anticoagulant activities of Tranilast."
Clinical Note
moderatePrasugrel + Resveratrol
"Prasugrel may increase the anticoagulant activities of Resveratrol."
Clinical Note
moderatePrasugrel + Nimesulide
"Prasugrel may increase the anticoagulant activities of Nimesulide."
Clinical Note
moderatePrasugrel + Epoprostenol
"Prasugrel may increase the antiplatelet activities of Epoprostenol."
The active metabolite has a terminal elimination half-life of about 7 hours (range 2–15 hours). This corresponds to once-daily dosing. Prasugrel itself is rapidly hydrolyzed and has a half-life of about 2 hours.
Pravastatin: 1.5-2 hours (terminal, clinical significance minimal due to prolonged HMG-CoA reductase inhibition); Aspirin: 15-20 minutes (acetylated form), salicylate: 2-3 hours (low dose) to 15-30 hours (high dose, due to saturable metabolism)
Approximately 68% of the dose is excreted in urine as inactive metabolites, and 27% in feces. No significant renal excretion of parent drug.
Pravastatin: ~20% renal, ~70% fecal (biliary); Aspirin: renal (dose-dependent, ~50-80% as salicylates, ~10-20% as salicyluric acid)
Category A/B
Category C
Antiplatelet
Antiplatelet/Statin Combination